Registered entities
Aryx Therapeutics, Inc
Reg. No. -Belgium
Innovation
36 patent families (26 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace dormant. Cited 1,044 times.
| Year | Filings |
|---|---|
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 4 |
| 2017 | 2 |
| 2018 | 2 |
Investor mix
10 investors on record; lead investors include Nomura, ITOCHU, Merlin Biomed Group, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Private equity | 1 | 10% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 1 | 10% |